Boehringer Ingelheim analysed UK Biobank and Genomics England data in place using Lifebit's federated research environment.
Boehringer needed governed access to large biobanks without moving regulated data and with standardised data. Lifebit deployed a federated Trusted Research Environment in its cloud, harmonising data to OMOP. The page reports target identification in 59 minutes versus months, 500K+ UK Biobank and 125K+ Genomics England participants analysed, 270+ analytical processes in one protocol and 90%+ faster validation.
Lifebit is a federated data and trusted research environment vendor, used by pharma and public health bodies to analyse sensitive genomic and clinical data in place
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Lifebit on its own site — read the original case study on lifebit.ai ↗
Related use cases
- 01Flatiron Health federated global oncology data analysis across jurisdictions with Lifebit.
- 02Lupus Research Alliance harmonised molecular and clinical data from 9+ CROs on a Lifebit federated platform.
- 03Genomics England analysed 2,500+ breast cancer genomes in a Lifebit federated environment.
- 04How Bioventus evolved their commercial strategy with real world data and intelligence
- 05Clarivate and CLEO diagnostics are making early detection of ovarian cancer a reality
- 06Making informed investment decisions (Attracting breakthrough innovations from academic research) - SPRIND case study